Histological findings in skeletal muscle of SARS-CoV2 infected patient

References

• Pernazza, A.; Mancini, M.; Rullo, E.; Bassi, M.; De Giacomo, T.; Della, R. C.; d’Amati, G. Early Histologic Findings of Pulmonary SARS-CoV-2 Infection Detected in a Surgical Specimen. Virchows Archiv. 2020, 477, 743–748. DOI: 10.1007/s00428-020-02829-1.
   PubMed Web of Science ®Google Scholar
• Fox, S. E.; Li, G.; Akmatbekov, A.; Harbert, J. L.; Lameira, F. S.; Brown, J. Q.; Vander Heide, R. S. Unexpected Features of Cardiac Pathology in COVID-19 Infection. Circulation. 2020, 142(11), 1123–1125. DOI: 10.1161/CIRCULATIONAHA.120.049465.
   PubMed Web of Science ®Google Scholar
• Sonzogni, A.; Previtali, G.; Seghezzi, M.; Grazia Alessio, M.; Gianatti, A.; Licini, L.; Morotti, D.; Zerbi, P.; Carsana, L.; Rossi, R.; et al. Liver Histopathology in Severe COVID 19 Respiratory Failure Is Suggestive of Vascular Alterations. Liver Int. 2020, 40(9), 2110–2116. DOI: 10.1111/liv.14601.
   PubMed Web of Science ®Google Scholar
• Su, H.; Yang, M.; Wan, C.; Yi, L. X.; Tang, F.; Zhu, H. Y.; Yi, F.; Yang, H. C.; Fogo, A. B.; Nie, X.; et al. Renal Histopathological Analysis of 26 Postmortem Findings of Patients with COVID-19 in China. Kidney Int. 2020, 98, 219–227. DOI: 10.1016/j.kint.2020.04.003.
   PubMed Web of Science ®Google Scholar
• Guidon, A. C.; Amato, A. A. COVID-19 and Neuromuscular Disorders. Neurology. 2020, 94(22), 959–969. DOI: 10.1212/WNL.0000000000009566.
   PubMed Web of Science ®Google Scholar
• Mageriu, V.; Bastian, A.; Alexianu, M.; Manole, E. Studiul Morfologic, Histoenzimatic Si Imunohistochimic Al Regresiei Leziunilor Musculare in Miopatiile Disimune Si Al Infiltratulu Inflamator Asociat Acestora in Urma Terapiri Corticosteroide. Congresul Natl Pentru Stud Si Tineri Med. 2015, 2015, 2285–9438.
   Google Scholar
• Nakamura, H.; Kinjo, T.; Arakaki, W.; Miyagi, K.; Tateyama, M.; Fujita, J. Serum Levels of Receptor-interacting Protein Kinase-3 in Patients with COVID-19. Crit. Care. 2020, 24(1). DOI: 10.1186/s13054-020-03209-6.
   Web of Science ®Google Scholar
• Belizário, J. E.; Neyra, J. M.; Setúbal Destro, R. M. F. When and How NK Cell-induced Programmed Cell Death Benefits Immunological Protection against Intracellular Pathogen Infection. Innate Immun. 2018, 24, 452–465. DOI: 10.1177/1753425918800200.
   PubMed Web of Science ®Google Scholar
• Shepherd, S.; Batra, A.; Lerner, D. P. Review of Critical Illness Myopathy and Neuropathy. Neurohospitalist. 2017, 7(1), 41–48. DOI: 10.1177/1941874416663279.
   PubMed Web of Science ®Google Scholar
• Moody, E., MD; Harrell, J., MD(2016). Critical Illness Myopathy. https://now.aapmr.org/critical-illness-myopathy/#diseasedisorder
   Google Scholar
• Chen, J.; Huijuan, W.; Yuanyuan, Y.; Tang, N. Pulmonary Alveolar Regeneration in Adult COVID-19 Patients. Cell Res. 2020. DOI: 10.1038/s41422-020-0369-7.
   Web of Science ®Google Scholar
• Greve, J. M. D.; Brech, G. C.; Quintana, M.; Soares, A. L.; De, S.; Alonso, A. C. Impacts of COVID-19 on the Immune, Neuromuscular, and Musculoskeletal Systems and Rehabilitation. Revista Brasileira De Medicina Do Esporte. 2020, 26, 285–288. DOI: 10.1590/1517-869220202604esp002.
   Web of Science ®Google Scholar
• Mageriu, V.; Manole, E.; Bastian, A. E.; Staniceanu, F. Role of Myokines in Myositis Pathogenesis and Their Potential to Be New Therapeutic Targets in Idiopathic Inflammatory Myopathies. J. Immunol. Res. 2020, 2020, 1–14. DOI: 10.1155/2020/9079083.
   Web of Science ®Google Scholar
• Mao, L.; Jin, H.; Wang, M.; Hu, Y.; Chen, S.; He, Q.; Chang, J.; Hong, C.; Zhou, Y.; Wang, D.; et al. Neurologic Manifestations of Hospitalized Patients with Coronavirus Disease 2019 in Wuhan, China. JAMA neurol. 2020, 77(6), 683. DOI: 10.1001/jamaneurol.2020.1127.
   PubMed Web of Science ®Google Scholar
• European Centre for Disease Prevention and Control, Clinical Characteristics of COVID-19, https://www.ecdc.europa.eu/en/covid-19/latest-evidence/clinical
   Google Scholar
• Zheng, F.; Tang, W.; Li, H.; Huang, Y. X.; Xie, Y. L.; Zhou, Z. G. Clinical Characteristics of 161 Cases of Corona Virus Disease 2019 (COVID-19) in Changsha. Eur. Rev. Med. Pharmacol. Sci. 2020. DOI: 10.26355/eurrev_202003_20711.
   Web of Science ®Google Scholar
• Chan, K. H.; Farouji, I.; Harnoud, A. A.;, et al. Weakness and Elevated Creatinine Kinase as the Initial Presentation of Coronavirus Disease 2019 (COVID-19). Am J Emergency Med 2020, 38, 1548.e1-1548.e3. DOI: 10.1016/j.ajem.2020.05.015.
   Web of Science ®Google Scholar